News
The gross national debt of the United States crossed the $32 trillion level on Friday. And all comments on the future indicate that the...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow Author and entrepreneur. My articles typically cover macroeconomic trends, portfolio strategy, value investing, and behavioral finance. I like...
News
This article was written by Follow Dhierin-Perkash Bechai is an aerospace, defense and airline analyst. Dhierin runs the investing group The Aerospace Forum, whose...
News
This article was written by Follow Yiannis Zourmpanos, founder of Yiazou IQ, an AI-driven stock research platform providing all-in-one stock reports. Experience: Previously worked...
News
Last week’s article called for higher, but the extent of this week’s move is surprising. The S&P 500 (SPY) blasted through 4400 to a...
News
~ by Snehasish Chaudhuri, MBA (Finance) Since February 2022, economic restrictions imposed on Russia by Western countries pushed energy prices and subsequent inflation to...
News
The EV Charging Investment Thesis Has Been Boosted By Recent Big Auto Development We previously covered ChargePoint (NYSE:CHPT) in March 2023. The stock had...
News
Co-authored with Treading Softly. When you were a kid, did your father bother you about turning off the lights? I realized I had become...
News
Right now, as investors get back into risk-taking mode, the market is suddenly re-discovering a lot of downtrodden tech stocks that were trading at...
News
BUD Has Fallen To The Cancel Culture We have previously covered Anheuser-Busch InBev SA/NV (BUD) in April 2023, suggesting that the controversy after the...
News
Introduction As a dividend growth investor, I seek investment opportunities in income-producing assets, mainly stocks. I usually add to existing positions when I find...
News
Amid the resurgence of optimism in the markets, we have to be careful of one thing: with investors piling back into tech stocks, we...
News
Introduction Founded in 2008, BioNTech (NASDAQ:BNTX) is an international leader in immunotherapy, aimed at innovating treatments for cancer, infectious diseases, and other severe illnesses....
